Introduction
============

Marine organisms containing symbiotic microorganisms, such as ascidians, sponges and soft corals, are a rich source of bioactive compounds \[1, 2a-b\]. Ascidians belong to the family Didemnidae, which frequently possess prokaryotic algae (cyanobacteria, *Prochloron* spp., etc.) \[[@B3-molecules-13-00595],[@B4-molecules-13-00595],[@B5-molecules-13-00595]\], and have yielded structurally unique and pharmacologically interesting compounds such as didemnenones, enterocins, paterallazoles, varacins and virenamides \[[@B6-molecules-13-00595],[@B7-molecules-13-00595],[@B8-molecules-13-00595],[@B9-molecules-13-00595],[@B10-molecules-13-00595]\]. In our search for bioactive compounds from Okinawan marine organisms \[[@B11-molecules-13-00595],[@B12-molecules-13-00595],[@B13-molecules-13-00595],[@B14-molecules-13-00595]\], we investigated the ascidian *Diplosoma virens*, which inhabits the coast of Hateruma Island. From this organism, we isolated compounds **1** and **2**, which are major constituents of its acetone extract. Antimicrobial metabolites **1** and **2**, previously isolated from the Caribbean sponge *Uloma* sp. in 1978 \[[@B15-molecules-13-00595]\], were characterized mainly by spectral analysis of their derivatives, including compounds such as acetates, methyl ethers and phenyltriazolinedione adducts. The physical properties of **2** and the ^13^C-NMR data for **1** have not been previously described in the literature \[[@B15-molecules-13-00595]\].

In this study, we confirmed the structure of **2** by interpreting its 2D-NMR data, and we provided full spectral data for **2** and **1**. In addition, the compounds' cytotoxity against HCT116 cells (human colorectal cancer cells) via apoptotic cell death was demonstrated.

Results and Discussion
======================

A specimen of *Diplosoma virens* (72 g, wet weight) was collected by hand from the coast of Hateruma Island, Okinawa, and extracted with acetone. The acetone extract was analyzed using ^1^H- NMR, and two major compounds were observed. The acetone extract was partitioned between aqueous MeOH and hexanes. The aqueous MeOH phase was concentrated *in vacuo* and then partitioned between CH~2~Cl~2~ and water. Purification of the CH~2~Cl~2~ extract by silica gel column chromatography followed by reversed-phase (C8) HPLC (H~2~O/MeOH) yielded compounds **1** (0.13%) and **2** (0.086%). When a solution of **1** or **2** in CH~2~Cl~2~ or MeOH was concentrated, a large portion of the resulting residue was no longer soluble in the organic solvents.

![Structures of compounds **1** and **2**.](molecules-13-00595-g001){#molecules-13-00595-f001}

Compound **1** was identified by performing comprehensive spectral analyses ([Figure 1](#molecules-13-00595-f001){ref-type="fig"} and [Table 1](#molecules-13-00595-t001){ref-type="table"}) and by comparing resulting spectral data with those in the literature \[[@B15-molecules-13-00595]\].

Analysis of the^13^C-NMR and HRFABMS data \[*m/z* 191.0691 (M + H)^+^, ∆ -1.7 mmu\] for compound **2** provided a molecular formula of C~11~H~10~O~3~, which suggested seven degrees of unsaturation. The IR absorption bands at 1680 and 3250 cm^-1^ indicated the presence of carbonyl and hydroxyl groups. The spectral data of compound **2** showed close similarities to those of **1**. The ^1^H- and ^13^C-NMR data analysis indicated the presence of a carbonyl carbon (*δ*~C~ 187.8), a *cis* double bond \[*δ*~C~ 134.2, 118.4; *δ*~H~ 6.17 (1H, ddd), 6.77 (1H, ddd)\], a tetrasubstituted double bond (*δ*~C~ 128.3, 147.5), a conjugated diene \[*δ*~C~ 131.6 (s), 136.6 (d); *δ*~H~ 6.65 (1H, br d) and *δ*~C~ 132.1 (d), 127.3 (t); *δ*~H~ 7.76 (1H, ddd), 5.57 (1H, dd), 5.61 (1H, dd)\], an oxygenated methine \[*δ*~C~ 71.9; *δ*~H~ 4.79 (1H, s)\] and an oxygenated methylene \[*δ*~C~ 67.2; *δ*~H~ 4.48 (1H, ddd), 4.57 (1H, ddd)\].

molecules-13-00595-t001_Table 1

###### 

^1^H- and ^13^C-NMR data for compounds **1** and **2**^a^.

        1       2                                                
  ----- ------- --- ------------------------------ -- ------- -- ------------------------------
  1     147.2                                         147.5      
  2     187.9                                         187.8      
  3     132.6                                         131.6      
  4     71.3        5.01 (s)                          71.9       4.79 (s)
  5α    67.1        4.50 (ddd, 18.5, 4.2, 2.0)        67.2       4.48 (ddd, 18.3, 4.2, 1.7)
  5β                4.61 (ddd, 18.5, 2.4, 2.4)                   4.57 (ddd, 18.3, 2.4, 2.4)
  6     134.0       6.17 (ddd, 10.0, 4.2, 2.4)        134.2      6.17 (ddd, 10.0, 4.2, 2.4)
  7     118.4       6.78 (br d, 10.0)                 118.4      6.77 (ddd, 10.0, 2.4, 1.7)
  8     129.1                                         128.3      
  9     133.6       7.04 (br d, 11.7)                 136.6      6.65 (br d, 11.5)
  10    132.4       6.89 (ddd, 16.8, 11.7, 10.0)      132.1      7.76 (ddd, 17.1, 11.5, 10.0)
  11α   127.9       5.64 (br d, 10.0)                 127.3      5.57 (dd, 10.0, 1.7)
  11β               5.71 (br d, 16.8)                            5.61 (dd, 17.1, 1.7)
  OH                6.08 (br s)                                  6.12 (br s)

^a^ ^1^H-NMR (400 MHz) and ^13^C-NMR (100 MHz) were recorded in CDCl~3~.

Extensive analysis of ^1^H-^1^H COSY demonstrated two isolated spin systems, C5-C7 and C9-C11 ([Figure 2](#molecules-13-00595-f002){ref-type="fig"}). The connectivity of the aforementioned partial structures was established from the HMBC correlations of H-4/C-1, H-4/C-2, H-9/C-2, H-4/C-3, H-9/C-3, H~2~-5/C-4, H-7/C-4, H-6/C-5, H-7/C-5, H-5/C-6, H-5/C-7, H-4/C-7, H-4/C-8, H-4/C-9, H-11/C-9, H-11/C-10 and H-9/C-11 as shown in [Figure 2](#molecules-13-00595-f002){ref-type="fig"}, to describe the entire carbon framework of **2**.

![Planar structure of **2** based on COSY and HMBC correlations.](molecules-13-00595-g002){#molecules-13-00595-f002}

The chemical shift of H-10 in **2** (δ~H~ 7.76) was at lower field than in **1** (δ~H~ 6.89) owing to the magnetic anisotropy effect of the carbonyl group and the chemical shift of H-9 in **2** (δ~H~ 6.65) was at higher field than in **1** (δ~H~ 7.04), suggesting a *Z* configuration for the C-3, 9 double bond of **2**. This was confirmed by an NOEDS experiment, in which NOE was observed between H-9 and H-4 ([Figure 3](#molecules-13-00595-f003){ref-type="fig"}).

![Selected NOEs of compounds **1** and **2**.](molecules-13-00595-g003){#molecules-13-00595-f003}

Biological Activities
---------------------

Compounds **1** and **2** showed cytotoxity against HCT116 cells (human colorectal cancer cells) in a dose dependent manner ([Figure 4](#molecules-13-00595-f004){ref-type="fig"}a). Necrosis is a form of traumatic cell death that results from acute cellular injury. In contrast, apoptosis is a form of programmed cell death involving a biochemical cascade that includes caspases and cysteine proteases. Caspase 3/7 exists downstream in the caspase cascade.

To examine the type of cell death induced by these compounds at 20 ppm, caspase 3/7 activity was measured in HCT116 cells in the presence of compounds **1** and **2**. Caspase 3/7 activity in cells treated with compounds **1** and **2** was expressed as percent induced, compared to control cells not treated with the compound ([Figure 4](#molecules-13-00595-f004){ref-type="fig"}b). The caspase 3/7 induction associated with compounds **1** and **2** were 53.6% and 73.6%, respectively, indicating that these compounds induce apoptotic cell death by activating caspases through the mitochondrial/cytochrome C stress pathway that begins with the release of cytochrome C from mitochondria \[[@B16-molecules-13-00595],[@B17-molecules-13-00595],[@B18-molecules-13-00595]\].

![Cytotoxicity and caspase 3/7 activity of compounds **1** and **2** against HCT116 cells. (a) Cytotoxicity of compounds **1** and **2**; (b) caspase 3/7 induction due to compounds **1** and **2**.](molecules-13-00595-g004){#molecules-13-00595-f004}

Conclusions
===========

In this study we isolated compounds **1** and **2**, constituents of the sponge *Uloma* sp. \[[@B15-molecules-13-00595]\], as major components of the ascidian *Diplosoma virens*, and we confirmed the structure of **2** by interpreting its 2D-NMR and MS data, thus providing full spectral data for **2** and **1**. Compounds **1** and **2** showed weak cytotoxity against HCT116 cells (human colorectal cancer cells) by triggering apoptotic cell death. C~11~ cyclopentenones (didemnenones) \[[@B6-molecules-13-00595]\] and the related compounds (nakienone and terpiodiene) \[[@B19-molecules-13-00595],[@B20-molecules-13-00595]\] have been isolated from ascidians, cyanobacteria and a sponge, respectively. Isolation of a series of the C~11~ compounds, including compounds **1** and **2**, from unrelated marine organisms supports the potential microbial origin of these compounds. Studies on the origin of compounds **1** and **2** and their bioactivities are under way in our laboratory.

Experimental
============

General
-------

Optical rotations were measured on a JASCO P-1020 polarimeter. UV spectra of the methanol solutions were measured on a JASCO V-550 spectrophotometer. IR spectra were recorded as dry films on a JASCO FT/IR-300 spectrometer. The ^1^H-, ^13^C-, and 2D-NMR spectra were recorded on a JEOL lambda 400 or a JEOL α-500 spectrometer, and ^1^H- and ^13^C- chemical shifts were referenced to the solvent peaks \[*δ*~H~ 7.24 and *δ*~C~ 77.0 in CDCl~3~\]. Mass spectra were measured on a Waters Quattro *micro* API triple quadruple mass analyzer. Open column chromatography was performed on Kieselgel 60 (70-230 mesh, Merck). Preparative HPLC was run on a Waters 600 multi solvent system using a reversed-phase column (YMC-Pack C8, 20 x 250 mm I. D., YMC). All solvents used were reagent grade.

Animal Collection
-----------------

The small yellowish green ascidian was collected at low tide from the coast of Hateruma Island, Okinawa (Japan) in April 2006, and identified as *Diplosoma virens* by Professor Euichi Hirose, University of the Ryukyus, Japan. The identified ascidian was kept frozen at -80˚C until used. A voucher specimen was deposited at the University of the Ryukyus (Specimen no. 070222).

Extraction and Purification
---------------------------

The ascidian (72 g, wet weight) was exhaustively extracted with acetone (100 mL, 3 times) and filtered. The filtrates were combined and concentrated *in vacuo* to remove acetone. The resulting residue was first partitioned between MeOH/H~2~O (9:1, 100 mL) and hexane (100 mL). The aqueous MeOH phase was concentrated *in vacuo*, and then the resulting mixture was partitioned between CH~2~Cl~2~ (100 mL) and water (100 mL). The CH~2~Cl~2~ extract was column chromatographed on Si gel eluting with CH~2~Cl~2~ (100 mL), CH~2~Cl~2~: EtOAc (1:1 v/v, 100 mL), EtOAc (200 mL) and MeOH (200 mL). One twentieth of the CH~2~Cl~2~ eluate which contained compounds **1** and **2** was concentrated, and then the residue was separated by reversed-phase HPLC (YMC-Pack C8) using a linear gradient of water (eluent A) and acetonitrile (eluent B), (0 min, 30% B; 1 min, 30% B; 10 min, 40 % B and 25 min, 60 % B; flow rate, 15 mL min^-1^) to furnish compounds **1** (*t*~R~ = 12.8 min, 4.8 mg) and **2** (*t*~R~ = 11.7 min, 3.1 mg).

*5-Hydroxy-7-prop-2-en-(E)-ylidene-7,7a-dihydro-2H-cyclopenta\[b\]pyran-6-one* (**1**). Pale yellow powder; \[α\]^21^~D~ +4.1 (*c* 0.15, MeOH); UV (MeOH) *λ*~max~ (log *ε*) 249 (4.4) and 347 (4.2) nm; FT/IR (film) *ν*~max~ 3250, 1680, 1620, 1420, 1360, 1220, 1150, 1080 and 770 cm^-1^; ^1^H- and ^13^C- NMR (CDCl~3~) data, see [Table 1](#molecules-13-00595-t001){ref-type="table"}; for UV, IR and ^1^H-NMR data refer to \[[@B15-molecules-13-00595]\]; LRESIMS *m/z* 191 (M+H)^+^, *m/z* 225 (M+Na)^+^ and *m/z* 189 (M-H)^-^; HRFABMS *m/z* (M+H)^+^ 191.0752 (calcd for C~11~H~11~O~3~, 191.0708).

*5-Hydroxy-7-prop-2-en-(Z)-ylidene-7,7a-dihydro-2H-cyclopenta\[b\]pyran-6-one* (**2**). Pale yellow powder; \[α\]^21^~D~ +11 (*c* 0.32, MeOH); UV (MeOH) *λ*~max~ 249 (log *ε*) (4.0), 346 (3.9) nm; FT/IR (film) *ν*~max~ 3250, 1680, 1620, 1420, 1350, 1220, 1080 and 780 cm^-1^; ^1^H- and ^13^C-NMR (CDCl~3~) data, see [Table 1](#molecules-13-00595-t001){ref-type="table"}; LRESIMS *m/z* 191 (M+H)^+^, *m/z* 225 (M+Na)^+^ and *m/z* 189 (M-H)^-^; HRFABMS *m/z* (M+H)^+^ 191.0691 (calcd for C~11~H~11~O~3~, 191.0708).

Biological Assay
----------------

*Cells:* HCT-116 cells (human colorectal cancer cells) were cultured in DMEM medium (including 10% FBS, 100 U/mL penicillin, and 100 ng/mL streptomycin) at 37˚C in a 5% CO~2~ atmosphere.

*Cell viability:* The MTT assay was used to examine the cell viability. Briefly, HCT116 cells were seeded at a density of 2.5 X 10^4^ cells/mL on 96-well plates and cultured for 17 hrs with or without the test compound. After incubation, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT, 0.5 mg/mL) was added to each well, the samples were again incubated for 3 hrs, and then they were removed from suspension. Extraction with DMSO (100 μL), measured at 570 nm, provided the reference for readings at 630 nm with a microplate reader (BIO-RAD Model 550, BIO-RAD, USA).

*Caspase activity:* HCT116 cells were plated at a density of 2.5 X 10 ^4^ cells on 96-well plates, which were incubated for 17 hrs with or without the test compound. Caspase activation in cultured cells was measured using the commercially available caspase-3/7 assay kit (Promega, USA), following the protocol supplied by the manufacturer. Each cultured cell in the well was incubated at room temperature for 2 hrs 30 min with 100 μL of proluminescent substrate containing Z-DEVD (Caspase-Glo^TM^ 3/7), provided with the kit. Following caspase cleavage, a substrate reacts with luciferase and releases light in the presence of ATP and oxygen. The luminescence of the reaction products was measured with a CL-detector (CLD-110, Tohoku Electronic Co.).
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*Sample Availability:* Samples of the compounds are available from authors.
